Drug intelligence / Profile preview

ofloxacin

Development stage
Approved
Lead developer
Daiichi Sankyo
Modality
Small Molecules
Administration
Intravenous, Ophthalmic, Oral, Otic, Topical
01

Overview

Ofloxacin is a synthetic fluoroquinolone antibiotic used to treat a wide range of bacterial infections in various parts of the body including the respiratory tract (such as pneumonia and bronchitis), urinary tract (including bladder and kidney infections), skin and soft tissue infections (such as cellulitis), prostatitis (prostate infection), pelvic inflammatory disease and certain sexually transmitted diseases like chlamydia and gonorrhea. It is also used in eye drops for superficial bacterial eye infections and ear drops for otitis media with tympanic membrane perforation[1][2][3][4][5]. Ofloxacin works by inhibiting bacterial DNA gyrase and topoisomerase IV—enzymes essential for DNA replication—thereby preventing cell division in bacteria[1][5][7]. It is bactericidal with broad-spectrum activity against both Gram-positive and Gram-negative organisms. Ofloxacin was patented in 1980 by Daiichi Sankyo (then Daiichi Seiyaku) in Japan; it received FDA approval in 1990[1][5]. The drug is available as a generic medication worldwide.

Brand names
FloxinFloxin I.V.OcufloxAbfloxAbofAciofloAcofloxActvidAdiosAerofloxAfdoz-OFloxal 3 mg/gFloxar-OZFloxavidFloxedolFloxikaFloxilFloximoxFloxinaFloxoday-OZ
Other names
Ofloxacine
02

Targets

Topo IV (Bacterial Topoisomerase IV)TOP2A (DNA topoisomerase II)DNA gyrase

Beyond the preview

Go deeper on ofloxacin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ofloxacin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call